Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

Similar articles for PubMed (Select 21539695)

1.

Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.

Ragni MV, Fogarty PJ, Josephson NC, Neff AT, Raffini LJ, Kessler CM.

Haemophilia. 2012 Jan;18(1):63-8. doi: 10.1111/j.1365-2516.2011.02554.x. Epub 2011 May 4.

PMID:
21539695
2.

Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).

Langley AR, Stain AM, Chan A, McLimont M, Chait S, Wu J, Poon MC, Card R, Israels SJ, Laferriere N, Klaassen RJ, Rivard GE, Cloutier S, Hawes S, Feldman B, Blanchette V.

Haemophilia. 2015 Jul;21(4):469-76. doi: 10.1111/hae.12713.

PMID:
26104147
3.

Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.

Castaman G, Rocino A, Mazzucconi MG, Zanon E, Gagliano F, Molinari AC.

Blood Transfus. 2015 May 14:1-8. doi: 10.2450/2015.0333-14. [Epub ahead of print]

4.

Unmeasured costs of haemophilia: the economic burden on families with children with haemophilia.

Price VE, Hawes SA, Bouchard A, Vaughan A, Jarock C, Kuhle S.

Haemophilia. 2015 Jul;21(4):e294-9. doi: 10.1111/hae.12715. Epub 2015 May 8.

PMID:
25955276
5.

The current status of prophylactic replacement therapy in children and adults with haemophilia.

Ljung R, Gretenkort Andersson N.

Br J Haematol. 2015 Jun;169(6):777-86. doi: 10.1111/bjh.13365. Epub 2015 Mar 29.

PMID:
25819695
6.

A new case of bacterial endocarditis in a child with severe Haemophilia A carrying a central venous access device.

De Rueda B, Santa Catalina S, Lucia F, García de la Calzada D, Aguilar C.

Haemophilia. 2015 May;21(3):e251-3. doi: 10.1111/hae.12658. Epub 2015 Mar 9. No abstract available.

PMID:
25754032
7.

Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data.

Manners PJ, Price P, Buurman D, Lewin B, Smith B, Cole CH.

J Rheumatol. 2015 May;42(5):885-90. doi: 10.3899/jrheum.141236. Epub 2015 Mar 1.

PMID:
25729030
8.

Comment on: Khair K. Compliance, concordance and adherence: what are we talking about? Haemophilia Sept 2014;20(5):601-3.

Duncan NA, Roberson CP, Shapiro AD.

Haemophilia. 2015 May;21(3):e235-6. doi: 10.1111/hae.12641. Epub 2015 Feb 16. No abstract available.

PMID:
25684136
9.

How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access.

Nijdam A, Kurnik K, Liesner R, Ljung R, Nolan B, Petrini P, Fischer K; PedNet study group.

Haemophilia. 2015 Jul;21(4):444-50. doi: 10.1111/hae.12613. Epub 2015 Jan 13.

PMID:
25582494
10.

Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II).

Kavakli K, Yang R, Rusen L, Beckmann H, Tseneklidou-Stoeter D, Maas Enriquez M; LEOPOLD II Study Investigators.

J Thromb Haemost. 2015 Mar;13(3):360-9.

PMID:
25546368
11.

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

Nijdam A, Altisent C, Carcao MD, Cid AR, Claeyssens-Donadel S, Kurnik K, Ljung R, Nolan B, Petrini P, Platokouki H, Rafowicz A, Thomas AE, Fischer K; PedNet and CANAL study groups.

Haematologica. 2015 Mar;100(3):e84-6. doi: 10.3324/haematol.2014.115709. Epub 2014 Dec 19. No abstract available.

12.

Neonatal circumcision in severe haemophilia: a survey of paediatric haematologists at United States Hemophilia Treatment Centers.

Kearney S, Sharathkumar A, Rodriguez V, Chitlur M, Valentino L, Boggio L, Gill J.

Haemophilia. 2015 Jan;21(1):52-7. doi: 10.1111/hae.12528. Epub 2014 Dec 4.

PMID:
25472876
13.

Adherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient survey.

Krishnan S, Vietri J, Furlan R, Duncan N.

Haemophilia. 2015 Jan;21(1):64-70. doi: 10.1111/hae.12533. Epub 2014 Dec 2.

PMID:
25470071
14.

A national survey of immunosuppression strategies for acquired haemophilia A.

Batty P, Palmer B, Chalmers E, Hay CR, Liesner R, Rangarajan S, Talks K, Williams M, Collins P, Hart DP.

Haemophilia. 2015 Jan;21(1):e73-6. doi: 10.1111/hae.12547. Epub 2014 Nov 24. No abstract available.

PMID:
25422109
15.

Climbing therapy under PK-tailored prophylaxis.

Stemberger M, Schmit E, Czepa D, Kurnik K, Spannagl M.

Hamostaseologie. 2014;34 Suppl 1:S13-6. doi: 10.5482/HAMO-14-01-0003.

PMID:
25382764
16.

Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population.

Nugent D, Kalnins W, Querol F, Gregory M, Pilgaard T, Cooper DL, Iorio A.

Haemophilia. 2015 Jan;21(1):e26-38. doi: 10.1111/hae.12545. Epub 2014 Nov 7.

PMID:
25377442
17.

[Prophylactic factor substitution in severe haemophilia A. Economic assessment in adult patients].

Berger K, Schopohl D, Eheberg D, Oldenburg J, Tiede A, Schramm W.

Hamostaseologie. 2014;34(4):291-300. doi: 10.5482/HAMO-14-03-0017. German.

PMID:
25370177
18.

Treatment decision-making among Canadian youth with severe haemophilia: a qualitative approach.

Lane SJ, Walker I, Chan AK, Heddle NM, Poon MC, Minuk L, Jardine L, Arnold E, Sholapur N, Webert KE.

Haemophilia. 2015 Mar;21(2):180-9. doi: 10.1111/hae.12543. Epub 2014 Oct 9.

PMID:
25296666
19.

Prophylaxis in adult patients with severe haemophilia A.

Oldenburg J, Brackmann HH.

Thromb Res. 2014 Nov;134 Suppl 1:S33-7. doi: 10.1016/j.thromres.2013.10.019. Epub 2014 Sep 26.

PMID:
25263019
20.

Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study.

Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J; LIPLONG Investigators.

Haemophilia. 2014 May;20(3):354-61.

PMID:
24847524
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk